Liposomal amikacin: Improved treatment of Mycobacterium avium complex infection in the beige mouse model

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 5, 1996, Pages 819-828

  Petersen, E A ^a   Grayson, J B ^a   Hersh, E M ^a   Dorr, R T ^a   Chiang, S M ^b   Oka, M ^b   Proffitt, R T ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b NeXtar Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; LIPOSOME;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG STABILITY; INTRAVENOUS DRUG ADMINISTRATION; LIVER; MORBIDITY; MORTALITY; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; NONHUMAN; PHOSPHOLIPID VESICLE; SPLEEN; SURVIVAL; TEMPERATURE;

EID: 0029822737     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.5.819     Document Type: Article

References (26)

1. Benson, C. A. & Ellner, J. J. (1993). Mycobacterium avium complex infection and AIDS: advances in theory and practice. Clinical Infectious Diseases 17, 7-20.
2. Bermudez, L. E., Wu, M. & Young, L. S. (1987). Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-encapsulated amikacin. Journal of Infectious Diseases 156, 510-3.
3. Bermudez, L. E., Yau-Young, A. O., Lin, J. P., Cogger, J. & Young, L. S. (1990). Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides. Journal of Infectious Diseases 161, 1262-8.
4. Bertram, M. A., Inderlied, C. B., Yadegar, S., Kolanoski, P., Yamada, J. K. & Young, L. S. (1986). Confirmation of the beige mouse model for study of disseminated infection with Mycobacterium avium complex. Journal of Infectious Diseases 154, 194-5.
5. Chaisson, R. E. & Hopewell, P. C. (1989). Mycobacteria and AIDS mortality. American Review of Respiratory Diseases 139, 1-3.
6. Chiu, J., Nussbaum, J., Bozzette, S., Tilles, J. G., Young, L. S., Leedom, J. et al. (1990). Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin ethambutol, rifampin, and ciprofloxacin. Annals of Internal Medicine 113, 358-61.
7. Cynamon, M. H., Swenson, C. E., Palmer, G. S. & Ginsberg, R. S. (1989). Liposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige mice. Antimicrobial Agents and Chemotherapy 33, 1179-83.
8. Duüzguünes, N., Perumal, V. K., Kesavalu, L., Goldstein, J. A., Debs, R. J. & Gangadharam, P. R. J. (1988). Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice. Antimicrobial Agents and Chemotherapy 32, 1404-11.
9. Gangadharam, P. R., Edwards, C. K., Murthy, P. S. & Pratt, P. F. (1983). An acute infection model for Mycobacterium intracellular disease using beige mice, preliminary results. American Review of Respiratory Diseases 127, 648-9.
10. Gangadharam, P. R., Perumal, V. K., Jairam, B. T., Rao, P. N., Nguyen, A. K., Farhi, D. C. et al. (1987). Activity of rifabutin alone or in combination with clofazimine or ethambutol or both against acute and chronic experimental Mycobacterium intracellulare infections. American Review of Respiratory Diseases 136, 329-33.
11. Heifets, L. B. (1991). Dilemmas and realities in drug susceptibility testing of M. avium-M. intracellulare and other slowly growing nontuberculous mycobacteria. In Drug Susceptibility in the Chemotherapy of Mycobacterial Infections (Heifets, L. B., Ed.), pp. 123-46. CRC Press, Boca Raton FL.
12. Heifets, L. B. & Iseman, M. D. (1990). Choice of antimicrobial agents for Mycobacterium avium disease based on quantitative tests of drug susceptibility. New England Journal of Medicine 323, 419-20.
13. Heifets, L. B., Iseman, M. D. & Lindholm-Levy, P. J. (1987). Determination of MICs of conventional and experimental drugs in liquid medium by the radiometric method against Mycobacterium avium complex. Drugs Under Experimental and Clinical Research 13, 529-38.
14. Horsburgh, C. R. (1991). Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. New England Journal of Medicine 324, 1332-8.
15. Inderlied, C. B., Kolonoski, P. T., Wu, M. & Young, L. S. (1989). Amikacin, ciprofloxacin, and imipenem treatment for disseminated Mycobacterium avium complex infection of beige mice. Antimicrobial Agents and Chemotherapy 33, 176-80.
16. Inderlied, C. B., Young, L. S. & Yamada, J. K. (1987). Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimycobacterial agents by various methods. Antimicrobial Agents and Chemotherapy 31, 1697-702.
17. Kawaguchi, H., Naito, T., Nakagawa, S. & Fujisawa, K. I. (1972). BB-K8, a new semisynthetic aminoglycoside antibiotic. Journal of Antibiotics 25, 695-708.
18. Kemper, C. A., Meng, T. C., Nussbaum, J., Chiu, J., Feigal, D. F., Bartok, A. E. et al. (1992). Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampicin, ethambutol, clofazime and ciprofloxacin. Annals of Internal Medicine 116, 466-72.
19. Kerlikowske, K. M., Katz, M. H., Chan, A. K. & Perez-Stable, E. J. (1992). Antimycobacterial therapy for disseminated Mycobacterium avium complex infection in patients with acquired immunodeficiency syndrome. Archives of Internal Medicine 152, 813-7.
20. Kesavalu, L., Goldstein, J. A., Debs, R. J., Duüzguünes, N. & Gangadharam, P. R. (1990). Differential effects of free and liposome encapsulated amikacin on the survival of Mycobacterium avium complex in mouse peritoneal macrophages. Tubercle 71, 215-7.
21. Khardori, N., Rolston, K., Rosenbaum, B., Hayat, S. & Bodey, G. P. (1989). Comparative in vitro activity of twenty antimicrobial agents against clinical isolates of Mycobacterium avium complex. Journal of Antimicrobial Chemotherapy 24, 667-73.
22. Meunier, F., Prentice, H. G. & Ringden, O. (1991). Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial. Journal of Antimicrobial Chemotherapy 28, Suppl B, 83-91.
23. Nightingale, S. D., Byrd, L. T., Southern, P. M., Jockush, J. D., Cal, S. X. & Wynne, B. A. (1992) Incidence of Mycobacterium avium intra-cellulare complex bacteremia in human immune-deficiency virus-positive patients. Journal of Infectious Diseases 165, 1082-5.
24. Proffitt, R. T., Satorius, A., Chiang, S.-M., Sullivan, L. & Adler-Moore, J. P. (1991). Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents. Journal Antimicrobial Chemotherapy 28, Suppl B, 49-61.
25. Rathbun, R. C., Martin, E. S., Eaton, V. E. & Matthew, E. B. (1991). Current and investigational therapies for AIDS-associated Mycobacterium avium complex disease. Clinical Pharmacy 10, 280-91.
26. Young, L. S., Wiviott, L., Wu, M., Kolonoski, P., Bolan, R. & Inderlied, C. B. (1991). Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS. Lancet 338, 1107-9.